α-hemolysin activity of methicillin-susceptible Staphylococcus aureus predicts ventilator-associated pneumonia

American Journal of Respiratory and Critical Care Medicine

Volumn 190, Issue 10, 2014, Pages 1139-1148

  Stulik, Lukas ^a   Malafa, Stefan ^a   Hudcova, Jana ^b   Rouha, Harald ^a   Henics, Bence Z ^a   Craven, Donald E ^b   Sonnevend, Agnes M ^c   Nagy, Eszter ^a  

^a Arsanis Biosciences ^*  (Austria)

^b LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^c UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Biomarker; Staphylococcus aureus; Ventilator associated pneumonia; hemolysin

Indexed keywords

AGAR; ALPHA HEMOLYSIN; ANTIBIOTIC AGENT; BACTERIAL TOXIN; HEMOLYSIN; STAPHYLOCOCCAL ALPHA-TOXIN; VIRULENCE FACTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; FEMALE; GENOTYPE; HEMOLYSIS; HLA TYPING; HUMAN; HUMAN CELL; INFECTIOUS COMPLICATION; LUNG ALVEOLUS EPITHELIUM CELL; MALE; MEDICAL DEVICE COMPLICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MOLECULAR TYPING; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STAPHYLOCOCCUS INFECTION; TRACHEAL ASPIRATION PROCEDURE; TRACHEOBRONCHITIS; VENTILATED PATIENT; VENTILATOR; VENTILATOR ASSOCIATED PNEUMONIA; VENTILATOR ASSOCIATED TRACHEOBRONCHITIS; AGED; ANIMAL; BRONCHITIS; COHORT ANALYSIS; DISEASE MODEL; DRUG EFFECTS; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; PNEUMONIA, VENTILATOR-ASSOCIATED; RISK FACTOR; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANIMALS; BACTERIAL TOXINS; BRONCHITIS; COHORT STUDIES; DISEASE MODELS, ANIMAL; FEMALE; HEMOLYSIN PROTEINS; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS;

EID: 84925365885     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201406-1012OC     Document Type: Article

References (46)

1. Bassetti M, Taramasso L, Giacobbe DR, Pelosi P. Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy. Expert Rev Anti Infect Ther 2012;10:585-596.
2. Valencia M, Torres A. Ventilator-associated pneumonia. Curr Opin Crit Care 2009;15:30-35. (Review).
3. Kollef MH, Hamilton CW, Ernst FR. Economic impact of ventilator-associated pneumonia in a large matched cohort. Infect Control Hosp Epidemiol 2012;33:250-256.
4. Craven DE, Lei Y, Ruthazer R, Sarwar A, Hudcova J. Incidence and outcomes of ventilator-associated tracheobronchitis and pneumonia. Am J Med 2013;126:542-549.
5. Nseir S, Ader F, Marquette CH. Nosocomial tracheobronchitis. Curr Opin Infect Dis 2009;22:148-153.
6. Grgurich PE, Hudcova J, Lei Y, Sarwar A, Craven DE. Diagnosis of ventilator-associated pneumonia: controversies and working toward a gold standard. Curr Opin Infect Dis 2013;26:140-150.
7. Nseir S, Favory R, Jozefowicz E, Decamps F, Dewavrin F, Brunin G, Di Pompeo C, Mathieu D, Durocher A; VAT Study Group. Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized, controlled, multicenter study. Crit Care 2008;12:R62.
8. Watkins RR, David MZ, Salata RA. Current concepts on the virulence mechanisms of meticillin-resistant Staphylococcus aureus. J Med Microbiol 2012;61:1179-1193.
9. Tong SY, Chen LF, Fowler VG Jr. Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance? Semin Immunopathol 2012;34:185-200.
10. Berube BJ, Bubeck Wardenburg J. Staphylococcus aureus α-toxin: nearly a century of intrigue. Toxins (Basel) 2013;5:1140-1166.
11. Adhikari RP, Ajao AO, Aman MJ, Karauzum H, Sarwar J, Lydecker AD, Johnson JK, Nguyen C, Chen WH, Roghmann MC. Lower antibody levels to Staphylococcus aureus exotoxins are associated with sepsis in hospitalized adults with invasive S. aureus infections. J Infect Dis 2012;206:915-923.
12. Fritz SA, Tiemann KM, Hogan PG, Epplin EK, Rodriguez M, Al-Zubeidi DN, Bubeck Wardenburg J, Hunstad DA. A serologic correlate of protective immunity against community-onset Staphylococcus aureus infection. Clin Infect Dis 2013;56:1554-1561.
13. Bubeck Wardenburg J, Schneewind O. Vaccine protection against Staphylococcus aureus pneumonia. J Exp Med 2008;205:287-294.
14. Foletti D, Strop P, Shaughnessy L, Hasa-Moreno A, Casas MG, Russell M, Bee C, Wu S, Pham A, Zeng Z, et al. Mechanism of action and in vivo efficacy of a human-derived antibody against Staphylococcus aureus a-hemolysin. J Mol Biol 2013;425:1641-1654.
15. Hua L, Hilliard JJ, Shi Y, Tkaczyk C, Cheng LI, Yu X, Datta V, Ren S, Feng H, Zinsou R, et al. Assessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumonia. Antimicrob Agents Chemother 2014;58:1108-1117.
16. Cheung GYC, Otto M. The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections. Expert Opin Ther Targets 2012;16:601-612.
17. Stulik L, Malafa S, Hudcova J, Rouha H, Henics BZ, Craven DE, Sonnevend AM, Nagy E. Evaluation of S. aureus isolates from endotracheal aspirates of ventilated patients. Presented at the International Symposium on Staphylococci & Staphylococcal Infections - ISSSI. August 26-29, 2014, Chicago, IL. Abstract A233.
18. Aanensen DM, Spratt, BG. The Multi-Locus Sequence Typing Network: mlst.net. Nucleic Acids Res 2005;33:W728-W733.
19. Harmsen D, Claus H, Witte W, Rothgänger J, Claus H, Turnwald D, Vogel U. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 2003;41:5442-5448.
20. Louie L, Goodfellow J, Mathieu P, Glatt A, Louie M, Simor AE. Rapid detection of methicillin-resistant staphylococci from blood culture bottles by using a multiplex PCR assay. J Clin Microbiol 2002;40:2786-2790.
21. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002;46:2155-2161.
22. Sau S, Bhasin N, Wann ER, Lee JC, Foster TJ, Lee CY. The Staphylococcus aureus allelic genetic loci for serotype 5 and 8 capsule expression contain the type-specific genes flanked by common genes. Microbiology 1997;143:2395-2405.
23. Dudeck MA, Weiner LM, Allen-Bridson K, Malpiedi PJ, Peterson KD, Pollock DA, Sievert DM, Edwards JR. National Healthcare Safety Network (NHSN) report, data summary for 2012, Device-associated module. Am J Infect Control 2013;41:1148-1166.
24. Agbaht K, Lisboa T, Pobo A, Rodriguez A, Sandiumenge A, Diaz E, Rello J. Management of ventilator-associated pneumonia in a multidisciplinary intensive care unit: does trauma make a difference? Intensive Care Med 2007;33:1387-1395.
25. Collins J, Rudkin J, Recker M, Pozzi C, O'Gara JP, Massey RC. Offsetting virulence and antibiotic resistance costs by MRSA. ISME J 2010;4:577-584.
26. Tenover FC, Tickler IA, Goering RV, Kreiswirth BN, Mediavilla JR, Persing DH; MRSA Consortium. Characterization of nasal and blood culture isolates of methicillin-resistant Staphylococcus aureus from patients in United States hospitals. Antimicrob Agents Chemother 2012;56:1324-1330.
27. Nichol KA, Adam HJ, Roscoe DL, Golding GR, Lagacé-Wiens PR, Hoban DJ, Zhanel GG; Canadian Antimicrobial Resistance Alliance. Changing epidemiology of methicillin-resistant Staphylococcus aureus in Canada. J Antimicrob Chemother 2013;68:i47-i55.
28. Hudson LO, Murphy CR, Spratt BG, Enright MC, Elkins K, Nguyen C, Terpstra L, Gombosev A, Kim D, Hannah P, et al. Diversity of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from inpatients of 30 hospitals in Orange County, California. PLoS ONE 2013;8:e62117.
29. Nair N, Kourbatova E, Poole K, Huckabee CM, Murray P, Huskins WC, Blumberg HM. Molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) among patients admitted to adult intensive care units: the STAR∗ICU trial. Infect Control Hosp Epidemiol 2011;32:1057-1063.
30. Roberts JC. Community-associated methicillin-resistant Staphylococcus aureus epidemic clone USA100; more than a nosocomial pathogen. Springerplus 2013;2:133.
31. O'Hara FP, Amrine-Madsen H, Mera RM, Brown ML, Close NM, Suaya JA, Acosta CJ. Molecular characterization of Staphylococcus aureus in the United States 2004-2008 reveals the rapid expansion of USA300 among inpatients and outpatients. Microb Drug Resist 2012;18:555-561.
32. Barretti P, Montelli AC, Batalha JE, Caramori JC, Cunha MdeL. The role of virulence factors in the outcome of staphylococcal peritonitis in CAPD patients. BMC Infect Dis 2009;9:212.
33. Malachowa N, Whitney AR, Kobayashi SD, Sturdevant DE, Kennedy AD, Braughton KR, Shabb DW, Diep BA, Chambers HF, Otto M, et al. Global changes in Staphylococcus aureus gene expression in human blood. PLoS ONE 2011;6:e18617.
34. Traber KE, Lee E, Benson S, Corrigan R, Cantera M, Shopsin B, Novick RP. agr function in clinical Staphylococcus aureus isolates. Microbiology 2008;154:2265-2274.
35. Villaruz AE, Bubeck Wardenburg J, Khan BA, Whitney AR, Sturdevant DE, Gardner DJ, DeLeo FR, Otto M. A point mutation in the agr locus rather than expression of the Panton-Valentine leukocidin caused previously reported phenotypes in Staphylococcus aureus pneumonia and gene regulation. J Infect Dis 2009;200:724-734.
36. Zielinska AK, Beenken KE, Joo HS, Mrak LN, Griffin LM, Luong TT, Lee CY, Otto M, Shaw LN, Smeltzer MS. Defining the strain-dependent impact of the Staphylococcal accessory regulator (sarA) on the alpha-toxin phenotype of Staphylococcus aureus. J Bacteriol 2011;193:2948-2958.
37. DeLeo FR, Kennedy AD, Chen L, Bubeck Wardenburg J, Kobayashi SD, Mathema B, Braughton KR, Whitney AR, Villaruz AE, Martens CA, et al. Molecular differentiation of historic phage-type 80/81 and contemporary epidemic Staphylococcus aureus . Proc Natl Acad Sci USA 2011;108:18091-18096.
38. Liang X, Hall JW, Yang J, Yan M, Doll K, Bey R, Ji Y. Identification of single nucleotide polymorphisms associated with hyperproduction of alpha-toxin in Staphylococcus aureus. PLoS ONE 2011;6:e18428.
39. Rudkin JK, Laabei M, Edwards AM, Joo HS, Otto M, Lennon KL, O'Gara JP, Waterfield NR, Massey RC. Oxacillin alters the toxin expression profile of community-associated methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2014;58:1100-1107.
40. Nielsen LN, Roggenbuck M, Haaber J, Ifrah D, Ingmer H. Diverse modulation of spa transcription by cell wall active antibiotics in Staphylococcus aureus. BMC Res Notes 2012;5:457.
41. Wunderink RG, Mendelson MH, Somero MS, Fabian TC, May AK, Bhattacharyya H, Leeper KV Jr, Solomkin JS. Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus. Chest 2008;134:1200-1207.
42. Sicot N, Khanafer N, Meyssonnier V, Dumitrescu O, Tristan A, Bes M, Lina G, Vandenesch F, Vanhems P, Etienne J, et al. Methicillin resistance is not a predictor of severity in community-acquired Staphylococcus aureus necrotizing pneumonia - results of a prospective observational study. Clin Microbiol Infect 2013;19:E142-E148.
43. Diep BA, Afasizheva A, Le HN, Kajikawa O, Matute-Bello G, Tkaczyk C, Sellman B, Badiou C, Lina G, Chambers HF. Effects of linezolid on suppressing in vivo production of staphylococcal toxins and improving survival outcomes in a rabbit model of methicillin-resistant Staphylococcus aureus necrotizing pneumonia. J Infect Dis 2013;208:75-82.
44. Luna CM, Sibila O, Agusti C, Torres A. Animal models of ventilator-associated pneumonia. Eur Respir J 2009;33:182-188.
45. Ramírez P, Ferrer M, Gimeno R, Tormo S, Valencia M, Piñer R, Menendez R, Torres A. Systemic inflammatory response and increased risk for ventilator-associated pneumonia: a preliminary study. Crit Care Med 2009;37:1691-1695.
46. Martin-Loeches I, Papiol E, Almansa R, López-Campos G, Bermejo-Martin JF, Rello J. Intubated patients developing tracheobronchitis or pneumonia have distinctive complement system gene expression signatures in the pre-infection period: a pilot study. Med Intensiva 2012;36:257-263.